According to the latest report by IMARC Group, titled “Covid-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The global COVID-19 diagnostics market size reached US$ 94.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.1 Billion by 2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
COVID-19 is a highly infectious disease generated by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat, body aches, etc. The infection is diagnosed through several clinical tests, such as reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing, etc. These tests use kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP), human saliva, nasal swabs, or blood. They are adopted by hospitals, laboratories, clinics, research institutes, and diagnostic centers.
Global Covid-19 Diagnostics Market Trends:
The sudden outbreak of coronavirus disease and a significant increase in the number of COVID-19 infected patients are primarily driving the global market for COVID-19 diagnostics. The escalating number of daily cases has resulted in the extensive adoption of diagnostic tests for rapid and comprehensive testing to facilitate early treatment for the patients. Additionally, the introduction of novel antibody and serology test kits for home-testing that consume less time and can be integrated with software-based programs for accurate results is further augmenting the product demand. Numerous other factors, including the launch of favorable government policies to contain the spread of COVID-19 infection and ongoing improvements in the healthcare infrastructures, are anticipated to drive the market growth in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/covid-19-diagnostics-market/requestsample
Global Covid-19 Diagnostics Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Becton Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffman-La Roche Ltd. (Roche Holding AG)
- Luminex Corporation
- PerkinElmer Inc.
- Quest Diagnostics Incorporated
- Robert Bosch GmbH
- Seegene Inc.
- Siemens Aktiengesellschaft
- Thermo Fisher Scientific Inc.
The report has segmented the market on the basis on region, product type, sample type, test type, mode and end use.
Breakup by Product Type:
- Reagents and Kits
Breakup by Sample Type:
- Nasopharyngeal Swabs
- Oropharyngeal Swabs
- Nasal Swabs
Breakup by Test Type:
- Molecular (RT-PCR) Testing
- Antigen-based Testing
- Antibody (Serology) Testing
Breakup by Mode:
- Point-of-Care (PoC)
- Non-Point-of-Care (Non-PoC)
Breakup by End Use:
- Diagnostic Centers and Clinics
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/covid-19-diagnostics-market
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal